See more : Lakeshore Acquisition I Corp. (LAAAW) Income Statement Analysis – Financial Results
Complete financial analysis of NeoPharm CO., LTD. (092730.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NeoPharm CO., LTD., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
You may be interested
- The Chiba Kogyo Bank, Ltd. (8337.T) Income Statement Analysis – Financial Results
- Pure Energy Minerals Limited (PEMIF) Income Statement Analysis – Financial Results
- Trematon Capital Investments Limited (TMT.JO) Income Statement Analysis – Financial Results
- VEON Ltd. (VEON) Income Statement Analysis – Financial Results
- China Energy Engineering Corporation Limited (3996.HK) Income Statement Analysis – Financial Results
NeoPharm CO., LTD. (092730.KQ)
About NeoPharm CO., LTD.
NeoPharm Co., Ltd. engages in the development, manufacture, and sale of cosmetics, medical, and health products. Its products include emulsified and functional skin care products for sensitive and dry skin, treatment of atopic dermatitis and psoriasis, and therapy for steroid side effects. The company was founded on July 1, 2000 and is headquartered in Daejeon, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 97.10B | 85.03B | 87.93B | 81.63B | 83.24B | 66.27B | 53.63B | 42.37B | 35.96B | 25.60B | 20.14B | 18.77B | 16.94B | 14.66B | 14.61B | 12.48B | 5.77B | 11.45B |
| Cost of Revenue | 32.95B | 27.76B | 26.62B | 24.09B | 23.96B | 18.31B | 13.85B | 10.90B | 9.93B | 6.85B | 5.07B | 4.69B | 4.44B | 3.27B | 2.91B | 2.54B | 1.15B | 2.36B |
| Gross Profit | 64.15B | 57.28B | 61.31B | 57.53B | 59.28B | 47.96B | 39.78B | 31.47B | 26.03B | 18.75B | 15.06B | 14.09B | 12.50B | 11.39B | 11.70B | 9.94B | 4.62B | 9.10B |
| Gross Profit Ratio | 66.06% | 67.36% | 69.73% | 70.48% | 71.22% | 72.37% | 74.17% | 74.28% | 72.38% | 73.23% | 74.80% | 75.03% | 73.80% | 77.72% | 80.08% | 79.66% | 80.10% | 79.43% |
| Research & Development | 2.57B | 2.85B | 2.86B | 2.64B | 2.36B | 2.53B | 2.10B | 2.18B | 1.78B | 1.62B | 1.60B | 0.00 | 1.80B | 2.19B | 1.49B | 1.01B | 310.49M | 1.02B |
| General & Administrative | 12.33B | 1.15B | 867.70M | 903.40M | 10.07B | 9.26B | 7.98B | 7.11B | 6.36B | 744.92M | 710.25M | 0.00 | 618.17M | 756.20M | 670.09M | 491.67M | 198.57M | 362.41M |
| Selling & Marketing | 23.94B | 21.87B | 26.00B | 23.72B | 23.89B | 17.01B | 15.65B | 12.57B | 11.64B | 7.56B | 7.01B | 0.00 | 5.91B | 4.07B | 4.18B | 2.85B | 1.57B | 2.59B |
| SG&A | 36.28B | 32.98B | 36.02B | 33.00B | 33.96B | 26.27B | 23.63B | 19.65B | 17.98B | 8.30B | 7.72B | 14.21B | 6.53B | 4.82B | 4.85B | 3.34B | 1.76B | 2.96B |
| Other Expenses | 0.00 | -87.28M | 4.19M | 129.54M | 0.00 | -470.00 | -100.00 | 0.00 | -18.06M | 3.83B | 3.60B | 0.00 | 2.97B | 4.07B | 3.40B | 2.10B | 944.92M | 1.70B |
| Operating Expenses | 38.92B | 35.84B | 38.88B | 35.64B | 36.32B | 28.81B | 25.72B | 21.83B | 19.78B | 13.75B | 12.92B | 13.98B | 11.30B | 11.09B | 9.74B | 6.45B | 3.02B | 5.68B |
| Cost & Expenses | 71.80B | 63.59B | 65.50B | 59.73B | 60.28B | 47.12B | 39.58B | 32.73B | 29.71B | 20.60B | 17.99B | 18.67B | 15.75B | 14.36B | 12.65B | 8.99B | 4.17B | 8.03B |
| Interest Income | 4.59B | 2.08B | 1.18B | 1.37B | 1.25B | 724.78M | 422.94M | 285.50M | 304.74M | 257.15M | 295.55M | 330.36M | 291.89M | 294.60M | 270.89M | 307.90M | 164.02M | 441.29M |
| Interest Expense | 21.32M | 8.84M | 38.46M | 56.37M | 17.17M | 2.08M | 130.00 | 250.00 | 1.46K | 7.95M | 11.41M | 7.42M | 31.75M | 42.36M | 20.40M | 22.30M | 10.07M | 52.67M |
| Depreciation & Amortization | 1.67B | 1.56B | 1.45B | 1.45B | 1.20B | 834.93M | 794.85M | 832.38M | 928.50M | 928.73M | 974.90M | 903.48M | 964.62M | 1.52B | 856.64M | 390.68M | 69.10M | 135.58M |
| EBITDA | 31.01B | 24.90B | 25.32B | 24.44B | 24.76B | 20.62B | 14.83B | 10.27B | 5.25B | 4.66B | 2.93B | 1.35B | 1.73B | 2.52B | 2.95B | 3.61B | 1.61B | 3.76B |
| EBITDA Ratio | 31.94% | 27.05% | 27.16% | 28.60% | 29.02% | 30.17% | 27.69% | 24.71% | 19.96% | 18.19% | 14.57% | 4.16% | 10.20% | 17.19% | 20.21% | 28.94% | 27.97% | 32.79% |
| Operating Income | 25.31B | 21.44B | 22.43B | 21.89B | 22.96B | 19.16B | 14.06B | 9.64B | 6.25B | 5.00B | 2.15B | -121.87M | 1.20B | 303.88M | 1.96B | 3.49B | 1.60B | 3.42B |
| Operating Income Ratio | 26.06% | 25.21% | 25.51% | 26.82% | 27.58% | 28.91% | 26.21% | 22.75% | 17.38% | 19.54% | 10.66% | -0.65% | 7.08% | 2.07% | 13.42% | 27.98% | 27.74% | 29.88% |
| Total Other Income/Expenses | 4.07B | 781.18M | 1.40B | 87.04M | -86.55M | 621.83M | -23.41M | -200.33M | -1.94B | -1.28B | -199.60M | 558.51M | -467.29M | 652.07M | 115.27M | -294.08M | -65.92M | 144.61M |
| Income Before Tax | 29.37B | 23.32B | 23.84B | 22.94B | 23.54B | 19.78B | 14.03B | 9.44B | 4.32B | 3.72B | 1.95B | 436.64M | 731.91M | 955.95M | 2.08B | 3.20B | 1.53B | 3.57B |
| Income Before Tax Ratio | 30.25% | 27.43% | 27.11% | 28.10% | 28.28% | 29.85% | 26.16% | 22.28% | 12.02% | 14.53% | 9.67% | 2.33% | 4.32% | 6.52% | 14.21% | 25.63% | 26.59% | 31.15% |
| Income Tax Expense | 6.16B | 6.30B | 6.12B | 4.81B | 4.30B | 4.41B | 2.47B | 1.70B | 914.70M | 1.15B | 52.99M | 211.12M | -172.33M | -334.07M | 20.62M | -88.27M | -263.63M | 60.01M |
| Net Income | 23.21B | 17.03B | 17.71B | 18.13B | 19.25B | 15.37B | 11.56B | 7.74B | 3.41B | 2.57B | 1.90B | 647.76M | 904.24M | 1.29B | 2.05B | 3.29B | 1.80B | 3.51B |
| Net Income Ratio | 23.90% | 20.02% | 20.14% | 22.21% | 23.12% | 23.19% | 21.55% | 18.27% | 9.47% | 10.03% | 9.41% | 3.45% | 5.34% | 8.80% | 14.07% | 26.33% | 31.17% | 30.62% |
| EPS | 1.48K | 2.18K | 2.26K | 2.32K | 2.57K | 2.17K | 1.63K | 1.09K | 481.61 | 361.00 | 258.00 | 87.00 | 122.00 | 174.00 | 307.00 | 505.00 | 902.56 | 1.99K |
| EPS Diluted | 2.97K | 2.18K | 2.26K | 2.30K | 2.54K | 2.15K | 1.62K | 1.09K | 481.61 | 361.00 | 258.00 | 87.00 | 122.00 | 174.00 | 307.00 | 505.00 | 902.56 | 1.99K |
| Weighted Avg Shares Out | 15.64M | 7.82M | 7.82M | 7.82M | 7.49M | 7.07M | 7.07M | 7.07M | 7.07M | 7.11M | 7.35M | 7.45M | 7.41M | 7.41M | 6.69M | 6.51M | 1.99M | 1.76M |
| Weighted Avg Shares Out (Dil) | 7.82M | 7.82M | 7.82M | 7.90M | 7.56M | 7.15M | 7.15M | 7.07M | 7.07M | 7.11M | 7.35M | 7.45M | 7.41M | 7.41M | 6.69M | 6.51M | 1.99M | 1.76M |
No news found for: 092730.KQ
Source: https://incomestatements.info
Category: Stock Reports